Publications by authors named "Camilla Labrie"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

126

Total Likes

239

Extended Reach

447,894

Social Features

84
I
Immunotherapy-activated T cells recruit and skew late-stage activated M1-like macrophages that are critical for therapeutic efficacy.
Marit J van Elsas, Jim Middelburg, Camilla Labrie, Jessica Roelands, Gaby Schaap, Marjolein Sluijter, Ruxandra Tonea, Vitalijs Ovcinnikovs, Katy Lloyd, Janine Schuurman

Cancer Cell· June 2024

Videos about Article: user user user 6

9 2 75

View All Article and Social Media Activity
N
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies.
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie

Cancer Immunol Res· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invasive margin tissue-resident macrophages of high CD163 expression impede responses to T cell-based immunotherapy.
Marit J van Elsas, Camilla Labrie, Anders Etzerodt, Pornpimol Charoentong, Jordi J C van Stigt Thans

J Immunother Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy.
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie

Cancer Res Commun· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy.
Christianne Groeneveldt, Priscilla Kinderman, Jordi J C van Stigt Thans, Camilla Labrie, Lisa Griffioen

J Immunother Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-6 signaling in macrophages is required for immunotherapy-driven regression of tumors.
Elham Beyranvand Nejad, Camilla Labrie, Marit J van Elsas, Jan Willem Kleinovink, Hans-Willi Mittrücker

J Immunother Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6-mediated resistance to immunotherapy is linked to impaired myeloid cell function.
Elham Beyranvand Nejad, Camilla Labrie, Tetje C van der Sluis, Suzanne van Duikeren, Kees L M C Franken

Int J Cancer· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy.
Elham Beyranvand Nejad, Camilla Labrie, Ziena Abdulrahman, Marit J van Elsas, Eva Rademaker

J Immunother Cancer· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis